Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01747 |
| Species: | Homo sapiens |
| Position : | chr11:2126750-2128050 |
| Year: | 2019 |
| Title: | Differential methylation of enhancer at IGF2 is associated with abnormal dopamine synthesis in major psychosis |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 31053723 |
| MONDO: | |
| Tissue: | Brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | Primary cortical neurons (NeuN+) |
| CVCL ID: | |
| Cell Type: | neuron |
| Cell Ontology ID: | CL:0000540 |
| Experiment Type: | Chromatin interaction assay |
| High Throughput Method: | Hi-C, WGBS, RNA-seq, Illumina MethylationEPIC microarray |
| Low Throughput Method: | Targeted bisulfite sequencing, RT-RT-qPCR, Western blot, HPLC |
| Target gene : | TH |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|